Two years ago, the BioE3 Policy set out to strengthen India’s biotechnology ecosystem and create new opportunities for industry.
As we mark its second anniversary, Dr Rahul Warke, Director, Research & Development (Microbiology), HiMedia Laboratories, speaks to Lakshmipriya Nair, Assistant Editor, Express Pharma, about HiMedia’s experience as one of the beneficiaries of the policy and what it means for industry.
What has the policy changed on the ground? Is it helping companies invest in R&D and scale up? And what more does industry need to turn India’s biotech potential into real opportunities?
Dr Warke shares his perspective on the journey so far and what comes next.